DK447488A - Forbedringer vedroerende anvendelsen af epidermal vaekstfaktor - Google Patents

Forbedringer vedroerende anvendelsen af epidermal vaekstfaktor

Info

Publication number
DK447488A
DK447488A DK447488A DK447488A DK447488A DK 447488 A DK447488 A DK 447488A DK 447488 A DK447488 A DK 447488A DK 447488 A DK447488 A DK 447488A DK 447488 A DK447488 A DK 447488A
Authority
DK
Denmark
Prior art keywords
egf
growth factor
epidermal growth
iron
value
Prior art date
Application number
DK447488A
Other languages
English (en)
Other versions
DK447488D0 (da
Inventor
Thomas James Greer Wilson
David Robert Tivey
Michael Waddington Smith
Peter Stephen James
Timothy John Peters
Kishor Barchand Raja
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868629674A external-priority patent/GB8629674D0/en
Priority claimed from GB878713169A external-priority patent/GB8713169D0/en
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of DK447488D0 publication Critical patent/DK447488D0/da
Publication of DK447488A publication Critical patent/DK447488A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/184—Hormones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Birds (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK447488A 1986-12-11 1988-08-10 Forbedringer vedroerende anvendelsen af epidermal vaekstfaktor DK447488A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB868629674A GB8629674D0 (en) 1986-12-11 1986-12-11 Promotion of animal growth
GB878713169A GB8713169D0 (en) 1987-06-05 1987-06-05 Uptake of iron by body
PCT/GB1987/000839 WO1988004180A1 (en) 1986-12-11 1987-11-24 Improvements in or relating to the use of epidermal growth factor

Publications (2)

Publication Number Publication Date
DK447488D0 DK447488D0 (da) 1988-08-10
DK447488A true DK447488A (da) 1988-08-10

Family

ID=26291686

Family Applications (1)

Application Number Title Priority Date Filing Date
DK447488A DK447488A (da) 1986-12-11 1988-08-10 Forbedringer vedroerende anvendelsen af epidermal vaekstfaktor

Country Status (10)

Country Link
EP (1) EP0292517B1 (da)
JP (1) JPH01501707A (da)
AT (1) ATE80307T1 (da)
AU (1) AU620797B2 (da)
CA (1) CA1315677C (da)
DE (1) DE3781682T2 (da)
DK (1) DK447488A (da)
GB (1) GB2198351B (da)
NZ (1) NZ222867A (da)
WO (1) WO1988004180A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149691A (en) * 1991-03-12 1992-09-22 Creative Biomolecules, Inc. Issue repair and regeneration through the use of platelet derived growth factor (pdgf) in combination with dexamethasone
US5753622A (en) 1995-05-10 1998-05-19 University Technologies International, Inc. Use of epidermal growth factor as a gastrointestinal therapeutic agent
CA2446398A1 (en) 2001-05-18 2002-11-28 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food Canada Nucleic acid and protein sequences of bovine epidermal growth factor
US20160296536A1 (en) * 2015-04-13 2016-10-13 Animal Biotech, LLC Administration of Glucocorticoid Steroids to Livestock

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3036917A (en) * 1959-11-10 1962-05-29 Upjohn Co Feeding ruminants 9alpha-fluoro-16alpha-methylprednisolone
US3259500A (en) * 1961-10-11 1966-07-05 Kentucky Res Foundation Method for inhibiting anemia in young pigs by feeding the sow an iron agent
NO116657B (da) * 1966-11-07 1969-04-28 Ewos Ab
US3737535A (en) * 1971-02-11 1973-06-05 J Brethour Method of fattening beef cattle
JPS6028999A (ja) * 1983-06-30 1985-02-14 Maruho Kk 細胞増殖促進作用を有するたんぱく質、その組成物と製造方法
GB8409960D0 (en) * 1984-04-17 1984-05-31 Searle & Co Therapeutic method

Also Published As

Publication number Publication date
GB8727493D0 (en) 1987-12-23
EP0292517A1 (en) 1988-11-30
DE3781682D1 (de) 1992-10-15
DE3781682T2 (de) 1993-01-21
GB2198351A (en) 1988-06-15
DK447488D0 (da) 1988-08-10
CA1315677C (en) 1993-04-06
EP0292517B1 (en) 1992-09-09
GB2198351B (en) 1990-07-11
WO1988004180A1 (en) 1988-06-16
NZ222867A (en) 1990-08-28
AU620797B2 (en) 1992-02-27
JPH01501707A (ja) 1989-06-15
ATE80307T1 (de) 1992-09-15
AU8275587A (en) 1988-06-30

Similar Documents

Publication Publication Date Title
MD1432C2 (ro) Metodă de tratament al stării dependente de estrogenii ovarieni
DE69434963D1 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
DE69012591D1 (de) Verwendung von Nikotin zur Herstellung eines Kit zur Behandlung von Krankheitszuständen, die auf eine Nikotinbehandlung ansprechen.
DE3867903D1 (de) Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle und diese mischkristalle enthaltende pharmazeutische mittel.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
NO302016B1 (no) Anordning for tilförsel i et legeme av innkapslet biologisk materiale
DK447488A (da) Forbedringer vedroerende anvendelsen af epidermal vaekstfaktor
DK0588477T3 (da) Medicinsk præparat omfatende TCF-11
GR3032224T3 (en) Therapeutic agent for threatened abortion.
Blanchet et al. Effects of methyl methacrylate monomer vapors on respiration and circulation in unanesthetized rats
TWI263502B (en) Pharmaceutical preparation for treating ischemic disease of heart or limbs
DE3877499D1 (de) 2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
Bramlage et al. Evaluation of stainless steel nerve caps for palmar digital neurectomy
FI961029A (fi) Menetelmä maksasairauden ja vastaavien indikaatioiden hoitamiseksi vasodilatoivilla aineilla
Africa An Act (No. 65 of 1983) to provide for the donation or the making available of human bodies and tissue for the purposes of medical or dental training, research or therapy or the advancement of medicine or dentistry in general; for the post-mortem examination of certain human bodies; for the removal of tissue, blood and gametes from the bodies of living persons and the use thereof for medical or dental purposes; for the control of the artificial insemination of persons; and for the regulation of the import and export of human tissue, blood and gametes; and to provide for matters connected therewith. Date of commencement: 12 July 1985 (the Human Tissue Act, 1983)
DK0612519T3 (da) Anvendelse af et calciumpræparat i et medikament til terapeutisk anvendelse på malkekøer, der lider af hypocalcaemia
Duncan Effect of anesthesia and surgery on the immune system.
Obitsu et al. A note on fitting re-entrant cannulae on the duodenum of growing young calves for determining of site and extent of utilization of nitrogen
Krizek Wound and reconstructive problems in advanced disease
Philpott Human Vibriosis
Short Warning of Massive Pulmonary Embolism
Shun-Shin Ingrowing Toenails
Webb Ophthalmic Graves's Disease
Wright A Case of Penicillin-Resistant Acute Hematogenous Osteomyelitis Treated With Aureomycin

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment